← FDA Drug Approvals (Drugs@FDA)
RIABNI
BLA · Biologics License Application · Sponsor: AMGEN INC · Approved 2020-12-17
Drug application
- FDA Application #
BLA761140- Application type
- Biologics License Application
- Brand name
- RIABNI
- Generic name
- RITUXIMAB-ARRX
- Active ingredients
- RITUXIMAB-ARRX
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- AMGEN INC
- Manufacturer
- Amgen, Inc
- First approval
- 2020-12-17
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown